Particulate Matter Exposure and the Changes in Immune Biomarkers: Effects of Biyeom-Go on the Nasal Mucosa of Patients with Allergic Rhinitis and a Particulate Matter-Treated Mouse Model
Table 2
The change of TNSS and mini-RQLQ.
Nasal symptoms
Baseline
4 weeks
Difference (baseline-4 weeks)
value
Nasal congestion
1.7 ± 0.7
1.1 ± 0.8
0.6 ± 0.9
0.0011
Rhinorrhea
1.6 ± 0.7
1.1 ± 0.8
0.5 ± 0.9
0.0067
Itching
1.3 ± 0.9
0.5 ± 0.6
0.7 ± 0.8
<.0001
Sneezing
1.5 ± 0.8
0.6 ± 0.7
0.9 ± 0.8
<.0001
TNSS
6.1 ± 2.3
3.4 ± 2.2
2.7 ± 2.6
<.0001
Mini-RQLQ
38.6 ± 11.9
19.3 ± 12.0
19.3 ± 12.8
<.0001
TNSS, total nasal symptom score; mini-RQLQ, mini‐rhinoconjunctivitis quality of life questionnaire. The values are expressed as the mean ± SD.
